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Background: cis-Diammineplatinum (II) dichloride (cisplatin) is the important anti-cancer agent useful in treatment
of various cancers. Unfortunately, it can produce unwanted side effects in various tissues, including the liver. The
present study investigated the possible protective role of curcumin and α-tocopherol against oxidative stress-induced
hepatotoxicity in rats upon cisplatin treatment.
Methods: Male Wistar rats were divided into five groups (n = 5). Saline and Cis groups, rats were intraperitoneal (i.p.)
injected with normal saline and cisplatin [20 mg/kg body weight (b.w.)], respectively. Cis + α-tocopherol group, Cis + Cur
group and Cis + α-tocopherol + Cur group, rats were pre-treated with a single dose of α-tocopherol (250 mg/kg b.w.),
curcumin (200 mg/kg b.w.) and combined α-tocopherol with curcumin, respectively, for 24 h prior the administration of
cisplatin. After 72 h of first injection, specimens were collected. Liver enzyme, lipid peroxidation biomarker, liver histopathology
and gene expression of liver nicotinamide adenine dinucleotide phosphate (NADPH) oxidase were investigated.
Results: Cisplatin revealed a significant increase of hepatic malondialdehyde (MDA) levels and a significant reduction of
hepatic superoxide dismutase (SOD) and catalase activities compared to the saline group. It elicited a marked increase
of the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels and demonstrated the liver
pathologies including liver congestion, disorganization of hepatic cords and ground glass appearance of hepatocytes. It
also demonstrated a significant increase of NADPH oxidase gene expression compared to saline group. Pre-treatment
with combined curcumin and α-tocopherol improved the liver enzymes, lipid peroxidation biomarker, liver histopathology
and gene expression of liver NADPH oxidase in cisplatin-treated rats.
Conclusions: The findings indicate that pre-treatment with combined curcumin and α-tocopherol can protect cisplatin-
induced hepatotoxicity including the biochemical, histological and molecular aspects. The down-regulations of NADPH
oxidase gene expression may be involved in abrogating oxidative stress via reduction of reactive oxygen species (ROS)
production.
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cis-Diammineplatinum (II) dichloride (cisplatin) is the
important chemotherapeutic agent useful in the treat-
ment of various cancers [1]. Unfortunately, it can pro-
duce side effects in various tissues, including the liver.
Although the mechanism of cisplatin-induced adverse
effect is still unclear, however several evidences have
shown that its hepatotoxicity is believed via reactive oxy-
gen species (ROS) generation-mediated oxidative stress* Correspondence: spalipoch@hotmail.com
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unless otherwise stated.dependent mechanism [2-4]. Oxidative stress is caused
by an imbalance between oxidant and antioxidant. It has
been implicated in the pathogenesis of various diseases
[5,6]. ROS are the highly reactive molecules which are
mainly composed of superoxide radical (O2
•-), hydroxyl
radical (•OH) and hydrogen peroxide (H2O2). It can
damage biological molecules including lipid, protein and
DNA and eventually cause disruption of the cellular
structural integrity and capacity [7]. NADPH oxidase is
a membrane-bound enzyme which has the ability to gen-
erate high levels of O2
•- in response to stimulus [8]. Pre-
vious studies revealed that the suppression of NADPHl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ology [9,10].
To prevent oxidative stress, there are several molecules
that play a role to scavenge ROS called antioxidant which
derived from both exogenous and endogenous sources.
Superoxide dismutase (SOD) is one of the most powerful
endogenous enzymatic antioxidants which has the ability
to convert O2
•- into H2O2. The absence of SOD demon-
strates the elevated oxidative damage causing various
pathologies in vivo [11,12]. Catalase is also the important
endogenous enzymatic antioxidant responsible for protec-
tion of the cell from oxidative damage induced by ROS via
converting H2O2 into water and oxygen. Catalase defi-
ciency leads to oxidative stress by increasing lipid peroxi-
dation as demonstrated in mice [13].
Medicinal plants are good sources of exogenous antioxi-
dants which might be considered as the new alternative
approach to ameliorate pathological alterations in oxida-
tive stress-related pathology. Curcumin is derived from
the rhizomes of Curcuma longa which has been demon-
strated to possess antioxidant activity in vivo [14]. It has
been demonstrated to prevent several pathologies related
to oxidative damage such as the inorganic arsenic-induced
hepatotoxicity [15]. We hypothesized that treatment with
combined curcumin and α-tocopherol may have higher
antioxidant ability than treatment with curcumin or α-
tocopherol alone. Additionally, α-tocopherol is one of the
most biologically active forms of vitamin E. The study
aimed at gaining insight into the understanding of the bio-
chemical, histological and molecular effects of curcumin
and/or α-tocopherol to protect against cisplatin-induced
oxidative stress in rat liver.
Methods
Chemicals
cis-Diammineplatinum (II) dichloride (product number:
479306, purity ≥ 99.9%), curcumin from Curcuma longa
(product number: c1386, purity ≥ 65%), α-tocopherol (prod-
uct number: 258024, purity ≥ 95.5%), Bradford assay kits
and 10% neutral buffered formalin solution were purchased
from Sigma-Aldrich Chemical Company (St. Louis, MO,
USA). Thiobarbituric Acid Reactive Substances (TBARS),
SOD and catalase assay kits were obtained from Cell Bio-
labs, Inc (San Diego, CA, USA). RNeasy mini kit, Omnis-
cript RT kit and HotStar Taq DNA polymerase were
obtained from Qiagen (Hilden, Germany). All other chemi-
cals were of analytical grade.
Animals
Twenty-five male Wistar rats (Rattus norvegicus), ranking
from 180-200 g, were obtained from the Division of Ani-
mal House, Faculty of Science, Prince of Songkla Univer-
sity, Thailand. All animal procedures were reviewed and
approved by the Animal Ethics Committee, WalailakUniversity (Protocol number: 004/2012) and were con-
ducted according to the Guide for the Care and Use of
Laboratory Animals, National Research Council. Rats were
maintained in stainless-steel cages under constant condi-
tions of temperature (23 ± 2°C), relative humidity (50-
60%) and lighting (12 h light/dark cycles). Animals were
provided with a standard commercial rat diet and distilled
water. Animals were acclimatized and closely monitored
under laboratory conditions for 2 weeks before the com-
mencement of the experiment.
Experimental design and specimen collection
Wistar rats were divided into five groups (5 rats per
group). Saline group, rats were treated with a single in-
traperitoneal (i.p.) injection of 1 ml of normal saline. Cis
group, rats were injected with a single dose of cisplatin
(20 mg/kg b.w.) via i.p. route. Cis + α-tocopherol group,
rats were treated with a single dose of α-tocopherol (250
mg/kg b.w.); Cis + Cur group, rats were treated with a
single dose of curcumin (200 mg/kg b.w.); and Cis + α-
tocopherol + Cur group, rats were treated with a single
dose of combined α-tocopherol (250 mg/kg b.w.) and
curcumin (200 mg/kg b.w.), via i.p. route for 24 h prior a
single dose injection of cisplatin (20 mg/kg b.w.) [16]. Fol-
lowing 72 h of first injection, rats were anesthetized with
thiopental sodium intraperitoneally (50 mg/kg b.w.). The
peripheral blood from heart was collected in clot activator
tubes. Then, rats were euthanized by anesthetizing thio-
pental sodium overdose (100 mg/kg b.w.). After opening
the abdominal cavity, the liver was harvested and immedi-
ately washed in ice-cold isotonic saline.
Determination of serum AST and ALT levels
Blood samples were centrifuged at 3000 rpm for 5 min.
Sera were collected and the levels of serum ALT and
AST were measured using a Cobas Mira Plus CC Chem-
istry Analyzer (Switzerland).
Determination of liver MDA levels
The liver tissue was homogenized to give a final concen-
tration of 50 mg/mL in phosphate buffered saline (PBS)
containing 1X butylated hydroxytoluene (BHT), homog-
enized on ice and centrifuged at 10000 × g for 5 min to
collect supernatant. In accordance with the protocol of
an OxiSelectTM TBARS Assay Kit (Cell Biolabs, Cat No.:
STA-330, San Diego, CA, USA), 100 μL of samples or
MDA standard was added to separate microcentrifuge
tubes, and then 100 μL of the SDS lysis solution was
added and mixed thoroughly. The samples were then in-
cubated for 5 min at room temperature, 250 μL of thio-
barbituric acid (TBA) reagent was added, and then each
tube was closed and incubated at 95°C for 60 min. The
tubes were then removed and cooled to room temperature
in an ice bath for 5 min. All sample tubes were then
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removed from the samples, and then finally 200 μL of
samples and MDA standard was transferred to a 96-well
microplate compatible with a spectrophotometric plate
reader. The absorbance was read at 532 nm.
Determination of liver SOD activity
The liver tissue was homogenized to give a final concen-
tration of 50 mg/ml in cold 1X lysis buffer (containing
10 mM Tris, pH 7.5, 150 mM NaCl and 0.1 mM EDTA),
centrifuged at 12000 × g for 10 min and the supernatant
was collected for analysis. In accordance with the proto-
col of an OxiSelect™ SOD Activity Assay Kit (Cell Bio-
labs, Cat No.: STA-340, San Diego, CA, USA), 20 μL of
samples, 5 μL of xanthine solution, 5 μL of chromagen
solution, 5 μL of 10X SOD assay buffer and 50 μL of de-
ionized water were added (total volume of 90 μL) to a
96-well microplate, and then 10 μL of pre-diluted 1X
xanthine oxidase solution was added to each well. The
samples were then mixed well and incubated for 1 h at
37°C. The absorbance was read using the spectrophoto-
metric microplate reader at 490 nm.
Determination of liver catalase activity
The liver tissue was homogenized to give a final concen-
tration of 50 mg/ml in cold PBS with 1mM EDTA, cen-
trifuged at 10000 × g for 15 min at 4°C and the
supernatant was collected. In accordance with the proto-
col of an OxiSelectTM Catalase Activity Assay Kit (Cell
Biolabs, Cat No: STA-341, San Diego, CA, USA), 20 μl
of the diluted catalase standard or sample and 50 μl of
the H2O2 working solution (12 mM) were added to a 96
well microplate. The samples were then mixed well and
incubated for 1 min. The reaction was stopped by add-
ing 50 μl of the catalase quencher into each well and
mixed thoroughly, 5 μl of each reaction well wasFigure 1 Serum AST levels (A) and serum ALT levels (B). Values represetransferred to a fresh well, 250 μl of the chromogenic
working solution was added to each well. The samples
were then mixed well and incubated for 60 min. The ab-
sorbance was read using the spectrophotometric micro-
plate reader at 520 nm.
Protein determination
Protein content was estimated by Bradford assay (Sigma,
USA) using bovine serum albumin (BSA) as standard.
Liver histology
The liver tissue was preserved in 10% neutral buffered
formalin solution for 24 h and washed with 70% ethanol.
Tissue was then placed in small metal caskets, stirred by
a magnetic stirrer, dehydrated using alcohol series from
70% to 100% alcohol and embedded in paraffin using an
embedding machine. Paraffin block was sectioned using
a rotary ultra-microtome, distributed onto glass slides
and then dried overnight. Slide was observed under a
light microscope after being stained with hematoxylin
and eosin (H&E) dyes and mounted.
Liver NADPH oxidase gene expression by reverse
transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the liver tissue by
RNeasy mini kit. RNA content and purity were mea-
sured by a UV spectrophotometer. RT-PCR was done
using the extracted RNA for detection of NADPH oxi-
dase gene. For amplification of the targets gene, reverse
transcription and PCR were run in two separate steps.
Briefly, Reaction mixture of RT reaction containing 1 μg
total RNA, 0.5 μg random primer, 5 × RT buffer, 2.5
mmol/l dNTP, 20 U RNase inhibitor and 200 U MMLV
reverse transcriptase in a total volume of 25 μl was incu-
bated at 37°C for 60 min, then heated to 95°C for 5 min
to inactivate MMLV. PCR was carried out with 1.5 μlnt the mean ± S.E.M. (n = 5). Cis: cisplatin, Cur: curcumin.
Figure 2 Liver MDA levels of study groups. Values represent the
mean ± S.E.M. (n = 5). Cis: cisplatin, Cur: curcumin.
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μl dNTP (2.5 mmol/l), 2.0 μl MgCl2 (25 mmol/l), 0.5 μl
each primer (20 μmol/l) of β-actin, 0.5 μl each primer of
gene to be tested (20 μmol/l) and 1 U of Taq DNA poly-
merase, in a final volume of 25 μl. Thermal cycler condi-
tions were as follows: a first denaturing cycle at 97°C for
5 min, followed by a variable number of cycles of ampli-
fication defined by denaturation at 96°C for 1.5 min, an-
nealing for 1.5 min and extension at 72°C for 3 min. A
final extension cycle of 72°C for 15 min was included
[17]. The primers including:
NADPH oxidase: Forward primer: 5’-GGAAATAGAA
AGTTGACTGGCCC -3’Figure 3 Enzymatic antioxidant activities of study groups: (A) SOD ac
(n = 5). Cis: cisplatin, Cur: curcumin.Reverse primer: 5’-GTATGAGTGCCATCCAGAGCAG-3’
Beta actin: Forward primer: 5’TGTTGTCCCTGTAT
GCCTCT-3’
Reverse primer: 5’-TAATGTCACGCACGATTTCC-3’
The sample was equally loaded on 2% gel agarose, stained
with ethidium bromide and visualized by UV transillumina-
tor. The amount of PCR product was quantified using the
gel and image analysis software (Syngene, USA).
Statistical analysis
Results were expressed as mean ± standard error of the
mean (S.E.M.). Differences between groups were deter-
mined by one-way analysis of variance (ANOVA). Post
hoc testing was performed for group comparisons using
the Least Significant Difference (LSD) test and p < 0.05
was considered significant.
Results
Effect of the treatment on liver enzymes
Cisplatin elicited a significant increase of the serum AST
and ALT levels compared to the control (saline) group
(p < 0.001) (Figures 1A and B). Curcumin and/or α-
tocopherol significantly demonstrated the reduction of
serum AST levels (p < 0.001) (Figure 1A). The alpha-
tocopherol group, curcumin group and combined curcu-
min with α-tocopherol group also significantly elicited
the reduction of the serum ALT levels compared to the
cisplatin-treated group (p = 0.022, p = 0.016 and p =
0.013, respectively) (Figure 1B).
Effect of the treatment on lipid peroxidation
Cisplatin demonstrated a marked increase of hepatic
MDA levels compared to the saline group (p < 0.001) indi-
cating the enhancement of lipid peroxidation (Figure 2).
The cisplatin pre-treated with curcumin group andtivity and (B) catalase activity. Values represent the mean ± S.E.M.
Figure 4 (See legend on next page.)
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Figure 4 Liver histology of study groups (H&E staining): (A, B) control group, (C, D) cisplatin-treated group, (E, F) cisplatin pre-treated
with α-tocopherol group, (G, H) cisplatin pre-treated with curcumin group and (I, J) cisplatin pre-treated with combined curcumin and
α-tocopherol group. The black asterisk indicates congestion. The green asterisk indicates disorganization of hepatic cords. The yellow asterisk
indicates ground glass appearance of hepatocytes. Scale bar = 100 and 20 μm, respectively. CV = central vein.
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significant reduce MDA levels compared to the cisplatin-
treated group (p = 0.013 and p = 0.008, respectively).
Effect of the treatment on enzymatic antioxidant activities
As shown in Figures 2A and 3B, cisplatin significantly
led to the reduction of SOD (p = 0.006) and calalase
activities (p < 0.001) compared to the saline group. The
cisplatin pre-treated with combined curcumin and α-
tocopherol group significantly elicited the increased
SOD activity compared to the cisplatin-treated group
(p = 0.003) and cisplatin pre-treated with α-tocopherol
group (p = 0.044) (Figure 3A). The cisplatin pre-treated
with curcumin group showed the significant increase of
catalase activity compared to the cisplatin-treated group
(p = 0.045). Moreover, the cisplatin pre-treated with
combined curcumin and α-tocopherol group signifi-
cantly elicited the increase of catalase activity compared
to the cisplatin-treated group (p = 0.001), cisplatin pre-
treated with α-tocopherol group (p = 0.010) and cisplatin
pre-treated with curcumin group (p = 0.039) (Figure 3B).
Effect of the treatment on liver histology
Cisplatin at 20 mg/kg b.w. caused liver congestion,
disorganization of hepatic cords and ground glass ap-
pearance of hepatocytes (Figures 4C and D). Pre-
treatment with curcumin and/or α-tocopherol was able
to improve liver pathology induced by cisplatin at 20
mg/kg b.w. (Figures 4E-J).Figure 5 Liver NADPH oxidase gene expressions in study groups. (A)
by RT-PCR and (B) density of NADPH oxidase gene compared with β-actin. VaEffect of the treatment on liver NADPH oxidase gene expression
As shown in Figures 5A and B, treatment with cisplatin
revealed a significant increase of mRNA levels of NADPH
oxidase compared to the saline group (p = 0.001). The
cisplatin pre-treated with combined curcumin and α-
tocopherol-treated groups significantly showed the re-
duction of mRNA levels of NADPH oxidase compared to
the cisplatin-treated group (p = 0.039).
Discussion
In the study, hepatotoxicity induced by cisplatin was rec-
ognized by the alterations of the biochemical, histological
and molecular parameters. Biochemical alterations in-
cluded the increase of liver enzyme levels including AST
and ALT, the increase of MDA levels and the decrease of
SOD and catalase activities. MDA is one of the most po-
tential biomarkers of lipid peroxidation [18]. Histological
changes comprised of liver congestion, disorganization of
hepatic cords and ground glass appearance of hepatocytes.
The molecular alteration indicates the up-regulation of
NADPH oxidase gene expression. From this study, we
suggest that up-regulation of NADPH oxidase gene ex-
pression may be caused the enhancement of ROS produc-
tion by increasing O2
•- production, ultimately resulting in
generation of lipid peroxidation. Lipid peroxidation is
demonstrated to induce disturbance of membrane func-
tion and integrity [19]. Moreover, the reduced activities of
enzymatic antioxidants led to the decreased scavenging
activities against ROS, eventually causing oxidative stress.agarose gel electrophoresis showing gene expression of NADPH oxidase
lues represent the mean ± S.E.M. (n = 5). Cis: cisplatin, Cur: curcumin.
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in various pathological conditions induced by oxidative
stress. The study indicates that oxidative stress has been
implicated in the pathogenesis of cisplatin-induced hep-
atotoxicity. Many studies have focused on the alternative
approach to protect cisplatin-induced hepatotoxicity using
natural products-derived antioxidants [2,20,21]. Our work
is the first report to demonstrate the combination of
curcumin and α-tocopherol for prevention of cisplatin-
induced hepatotoxicity.
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-hep-
tadiene-3,5-dione] is a natural phenolic compound from
turmeric which has demonstrated a variety of pharmaco-
logical effects such as antioxidant against hexavalent chro-
mium [Cr(VI)] compound-induced renal oxidant damage,
anti-inflammation against neurodegenerative, cardiovascu-
lar, pulmonary, metabolic, autoimmune and neoplastic dis-
eases, anti-cancer and enhanced wound healing [22-24].
Curcumin has been reported as the powerful antioxidant in
different in vitro assays. H-atom donation from phenolic
group of curcumin was believed to responsible for the su-
perb antioxidant properties [25]. Moreover, the phenolic
compound of curcumin has been confirmed to play the key
role in the antioxidant activity [26]. Additionally, curcumin
exhibited the highest antioxidant capacity compared to
turmeric’s other two curcuminoids including demethoxy-
curcumin and bisdemethoxycurcumin [27]. This study re-
vealed that pre-treatment with curcumin alone was able to
normalize the levels of liver enzymes and lipid peroxidation
biomarker, the activity of catalase and liver histopathology
in cisplatin-treated rats. The activities of curcumin were
similar to previous reports [28,29].
Alpha-tocopherol is an isoform of lipid-soluble vitamin E
which acts as a powerful antioxidant [30,31]. The pre-
treatment with combined curcumin and α-tocopherol led
to the improvement of the liver enzymes levels and lipid
peroxidation biomarker, the activities of enzymatic antioxi-
dants, liver histopathology and gene expression of liver
NADPH oxidase in cisplatin-treated rats. Previous reports
also showed the augmented activity of combined curcumin
with other antioxidant compound. Combination of ascorbic
acid with curcumin increases the antioxidant activity [32].
Co-administration of vitamin E and curcumin improved
the activities of enzymatic antioxidant including cytosolic
catalase, cytosolic glutathione peroxidase-1 (GPx1), mito-
chondrial SOD2 and glutathione reductase, and normalized
GPx1 protein expression in l-thyroxine-induced hyperthy-
roidism in rat [33]. From the results, we suggested that
NADPH oxidase play the key role in oxidative stress
state induced by cisplatin. Previous studies indicated that
NADPH oxidase is the main enzymatic source of ROS pro-
duction which is responsible for oxidative stress in various
diseases via the underlying mechanisms of NADPH oxidase
activation [34,35]. This study demonstrated the potentantioxidant property of combined curcumin and α-
tocopherol to reduce oxidative damages of liver induced by
cisplatin. However, the exact mechanism is still unknown.
The down-regulations of NADPH oxidase gene expression
may be involved in the abrogation of oxidative stress via re-
duction of reactive oxygen species (ROS) generation.
Conclusions
We suggest that oxidative stress has been implicated in
the pathogenesis of cisplatin-induced hepatotoxicity by
enhancing ROS generation through up-regulation of
NADPH oxidase gene and by reducing activities of en-
zymatic antioxidants. These findings indicate that pre-
treatment with combined curcumin and α-tocopherol
can protect cisplatin-induced hepatotoxicity including
biochemical, histological and molecular aspects. The
study provides the evidence of combined curcumin and
α-tocopherol as the new adjuvant of cisplatin to abrogate
the hepatotoxicity upon cancer chemotherapy.
Abbreviations
ALT: Alanine aminotransferase; ANOVA: Analysis of variance, AST, Aspartate
aminotransferase; b.w: Body weight; BHT: Butylated hydroxytoluene; BSA: Bovine
serum albumin; Cisplatin: cis-Diammineplatinum (II) dichloride; Cr(VI): hexavalent
chromium; DNA: Deoxyribonucleic acid; EDTA: Ethylenediaminetetraacetic acid;
GPx: Glutathione peroxidase; H&E: Hematoxylin and eosin; H2O2: Hydrogen
peroxide; i.p: Intraperitoneal; LSD: Least significant difference; MDA: Malondialdehyde;
MgCl2: Magnesium chloride; NaCl: Sodium chloride; NADPH oxidase: Nicotinamide
adenine dinucleotide phosphate oxidase; O2: Superoxide radical; OH: Hydroxyl
radical; PBS: Phosphate buffered saline; RNA: Ribonucleic acid; ROS: Reactive oxygen
species; RT-PCR: Reverse transcription-polymerase chain reaction; S.E.M.: Standard
error of the mean; SDS: Sodium dodecyl sulfate; SOD: Superoxide dismutase;
TBA: Thiobarbituric acid; TBARS: Thiobarbituric acid reactive substances.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SP conceived this study, and designed the experiments and performed most
of the experiments. CP contributed to the liver histology analysis. PK carried
out the liver SOD and catalase analysis. All authors analyzed the data, and
discussed and concluded the results. SP and PS provided final editing to the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This research was supported by a grant from the Institute of Research and
Development (under the contract WU 55307), Walailak University, Thailand.
We are thankful to Miss Dararat Punwong, Medical Technologist from School
of Allied Health Sciences and Public Health, Walailak University for laboratory
assistant and also thank the Dean and all staff of School of Medicine,
Walailak University for their kind support.
Author details
1School of Medicine, Walailak University, Nakhon Si Thammarat 80161, Thailand.
2Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok
10400, Thailand.
Received: 12 November 2013 Accepted: 24 March 2014
Published: 28 March 2014
References
1. Rabik CA, Dolan ME: Molecular mechanisms of resistance and toxicity
associated with platinating agents. Cancer Treat Rev 2007, 33:9–23.
2. Liao Y, Lu X, Lu C, Li G, Jin Y, Tang H: Selection of agents for prevention
of cisplatin-induced hepatotoxicity. Pharmacol Res 2008, 57(2):125–131.
Palipoch et al. BMC Complementary and Alternative Medicine 2014, 14:111 Page 8 of 8
http://www.biomedcentral.com/1472-6882/14/1113. Palipoch S, Punsawad C: Biochemical and histological study of rat liver and
kidney injury induced by Cisplatin. J Toxicol Pathol 2013, 26(3):293–299.
4. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003, 23:460–464.
5. Robbins MEC, Zhao W, Davis CS, Toyokuni S, Bonsib SM: Radiation-induced
kidney injury: a role for chronic oxidative stress? Micron 2002, 33(2):133–141.
6. MacNee W: Oxidative stress and lung inflammation in airways disease.
Eur J Pharmacol 2001, 429(1–3):195–207.
7. Palipoch S: A review of oxidative stress in acute kidney injury: protective
role of medicinal plants-derived antioxidants. Afr J Tradit Complement
Altern Med 2013, 10:88–93.
8. Babior BM: NADPH oxidase. Curr Opin Immunol 2004, 16:42–47.
9. Pan X, Dai Y, Li X, Niu N, Li W, Liu F, Zhao Y, Yu Z: Inhibition of arsenic
induced-rat liver injury by grape seed exact through suppression of
NADPH oxidase and TGF-β/Smad activation. Toxicol Appl Pharmacol 2011,
254(3):323–331.
10. Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen
RT, Takayanagi R: Vasoactive intestinal peptide reduces oxidative stress in
pancreatic acinar cells through the inhibition of NADPH oxidase. Peptides
2011, 32(10):2067–2076.
11. Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, Strong R, Huang T-T,
Epstein CJ, Roberts LJ 2nd, Csete M, Faulkner JA, Van Remmen H: Absence
of CuZn superoxide dismutase leads to elevated oxidative stress and
acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol
Med 2006, 40(11):1993–2004.
12. Kessova IG, Ho Y-S, Thung S, Cederbaum AI: Alcohol-induced liver injury in mice
lacking Cu, Zn-superoxide dismutase. Hepatology 2003, 38(5):1136–1145.
13. Kim SJ, Lee JW, Jung YS, Kwon DY, Park HK, Ryu CS, Kim SK, Oh GT, Kim YC:
Ethanol-induced liver injury and changes in sulfur amino acid
metabolomics in glutathione peroxidase and catalase double knockout
mice. J Hepatol 2009, 50(6):1184–1191.
14. M. Khopde S, Priyadarsini KI, Venkatesan P, Rao MNA: Free radical
scavenging ability and antioxidant efficiency of curcumin and its
substituted analogue. Biophys Chem 1999, 80(2):85–91.
15. Gao S, Duan X, Wang X, Dong D, Liu D, Li X, Sun G, Li B: Curcumin
attenuates arsenic-induced hepatic injuries and oxidative stress in experimental
mice through activation of Nrf2 pathway, promotion of arsenic methylation
and urinary excretion. Food Chem Toxicol 2013, 59:739–747.
16. Palipoch S, Punsawad C, Chinnapun C, Suwannalert P: Amelioration of
cisplatin-induced nephrotoxicity in rats by curcumin and α-tocopherol.
Trop J Pharm Res 2013, 12(6):973–979.
17. Rashed LA, Hashem RM, Soliman HM: Oxytocin inhibits NADPH oxidase
and P38 MAPK in cisplatin-induced nephrotoxicity. Biomed Pharmacother
2011, 65:474–480.
18. Horton AA, Fairhurst S: Lipid peroxidation and mechanisms of toxicity.
Crit Rev Toxicol 1987, 18(1):27–79.
19. Etsuo N: Lipid peroxidation: Physiological levels and dual biological
effects. Free Radic Biol Med 2009, 47(5):469–484.
20. Kart A, Cigremis Y, Karaman M, Ozen H: Caffeic acid phenethyl ester
(CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp Toxicol
Pathol 2010, 62(1):45–52.
21. Hassan I, Chibber S, Naseem I: Ameliorative effect of riboflavin on the
cisplatin induced nephrotoxicity and hepatotoxicity under
photoillumination. Food Chem Toxicol 2010, 48(8–9):2052–2058.
22. Molina-Jijón E, Tapia E, Zazueta C, El Hafidi M, Zatarain-Barrón ZL, Hernández-
Pando R, Medina-Campos ON, Zarco-Márquez G, Torres I, Pedraza-Chaverri J:
Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial
pathway. Free Radic Biol Med 2011, 51(8):1543–1557.
23. Aggarwal BB, Harikumar KB: Potential therapeutic effects of curcumin, the
anti-inflammatory agent, against neurodegenerative, cardiovascular,
pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem
Cell Biol 2009, 41(1):40–59.
24. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC: Multiple biological
activities of curcumin: a short review. Life Sci 2006, 78(18):2081–2087.
25. Ak T, Gülçin İ: Antioxidant and radical scavenging properties of curcumin.
Chem Biol Interact 2008, 174(1):27–37.
26. Galano A, Álvarez-Diduk R, Ramírez-Silva MT, Alarcón-Ángeles G, Rojas-Hernández
A: Role of the reacting free radicals on the antioxidant mechanism of
curcumin. Chem Phys 2009, 363(1–3):13–23.
27. Jayaprakasha GK, Jaganmohan Rao L, Sakariah KK: Antioxidant activities of
curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem
2006, 98(4):720–724.28. Naik SR, Thakare VN, Patil SR: Protective effect of curcumin on experimentally
induced inflammation, hepatotoxicity and cardiotoxicity in rats: Evidence of
its antioxidant property. Exp Toxicol Pathol 2011, 63(5):419–431.
29. Eybl V, Kotyzova D, Koutensky J: Comparative study of natural antioxidants –
curcumin, resveratrol and melatonin - in cadmium-induced oxidative dam-
age in mice. Toxicology 2006, 225(2–3):150–156.
30. Banudevi S, Krishnamoorthy G, Venkataraman P, Vignesh C, Aruldhas MM,
Arunakaran J: Role of α-tocopherol on antioxidant status in liver, lung
and kidney of PCB exposed male albino rats. Food Chem Toxicol 2006,
44(12):2040–2046.
31. Sodhi S, Sharma A, Brar APS, Brar RS: Effect of α tocopherol and selenium
on antioxidant status, lipid peroxidation and hepatopathy induced by
malathion in chicks. Pestic Biochem Phys 2008, 90(2):82–86.
32. Khalil OAK, de Faria Oliveira OMM, Vellosa JCR, de Quadros AU, Dalposso
LM, Karam TK, Mainardes RM, Khalil NM: Curcumin antifungal and antioxidant
activities are increased in the presence of ascorbic acid. Food Chem 2012,
133(3):1001–1005.
33. Subudhi U, Chainy GBN: Expression of hepatic antioxidant genes in
l-thyroxine-induced hyperthyroid rats: Regulation by vitamin E and
curcumin. Chem Biol Interact 2010, 183(2):304–316.
34. Huang X, Sun M, Li D, Liu J, Guo H, Dong Y, Jiang L, Pan Q, Man Y, Wang S,
Li J: Augmented NADPH oxidase activity and p22phox expression in
monocytes underlie oxidative stress of patients with type 2 diabetes
mellitus. Diabetes Res Clin Pract 2011, 91(3):371–380.
35. Qin F, Simeone M, Patel R: Inhibition of NADPH oxidase reduces
myocardial oxidative stress and apoptosis and improves cardiac function
in heart failure after myocardial infarction. Free Radic Biol Med 2007,
43(2):271–281.
doi:10.1186/1472-6882-14-111
Cite this article as: Palipoch et al.: Hepatoprotective effect of curcumin
and alpha-tocopherol against cisplatin-induced oxidative stress. BMC
Complementary and Alternative Medicine 2014 14:111.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
